پژوهش در طب ورزشی و فناوری

تاثیر دوازده هفته تمرین تداومی و تمرین تناوبی با شدت بالا بر سطوح برخی هپاتوکاین های سرم در مردان چاق

مقالات آماده انتشار

نویسندگان

اکبر گنج خانی
طاهره باقرپور
نعمت الله نعمتی

دانشگاه آزاد دامغان

چکیده
مقدمه:. هدف از پژوهش حاضر بررسی تاثیر تمرینات تداومی و تناوبی با شدت بالا روی فتوئین A و فتوئین B سرمی در مردان چاق بود.

روش: برای این منظور 45 مرد چاق (وزن بدن: 41/1±65/94 کیلوگرم، سن: 5±26 سال، BMI: kg.m2 41/62±1/33) داوطلب بعد از همگن­سازی بر اساس ویژگی‌های فردی و به روش تصادفی به 3 گروه کنترل (15 نفر)، تمرین تداومی (15 نفر)، تمرین تناوبی (15 نفر) تقسیم شدند. تمرینات در 12 هفته و 3 جلسه در هر هفته انجام شد . تمرین تناوبی شامل6 وهله ی 3 دقیقه­ای دویدن با شدت معادل90% حداکثر اکسیژن مصرفی و بین هر وهله 3 دقیقه دویدن به عنوان استراحت فعال با شدت معادل 50% حداکثر اکسیژن مصرفی روی تردمیل بود. تمرین تداومی نیز شامل 50 دقیقه دویدن با شدت معادل 70% حداکثر اکسیژن مصرفی دویدن روی تردمیل بود. نمونه خونی قبل و 48 ساعت بعد از آخرین جلسه تمرین گرفته شد و برای آنالیز شاخص‌ها با استفاده از دستگاه الایزا مورد استفاده قرار گرفت.

نتایج: آنالیز سطوح پلاسمایی فتوئین A و فتوئین B با آزمون تحلیل کوواریانس نشان داد که تفاوت بین گروهی (کنترل، MICT و HIIT) از نظر آماری معنادار بوده است (001/0>p). بر اساس نتایج حاصل از آزمون تعقیبی بونفرونی برای سطوح فتوئین A، تفاوت معناداری بین گروه­های HIIT (001/0>p) و MICT (007/0=p) با گروه کنترل وجود داشت. همچنین بر اساس نتایج حاصل از آزمون تعقیبی بونفرونی برای سطوح فتوئین B، تفاوت معناداری بین گروه­های HIIT (001/0>p) و MICT (001/0>p) با گروه کنترل وجود داشت. علاوه بر این، کاهش فتوئین B در گروه HIIT نسبت به گروه MICT از نظر آماری معنادار بود (001/0>p).

نتیجه گیری: نتایج حاضر نشان داد که باوجود تاثیرات مثبت هر دو نوع تمرین MICT و HIIT در کاهش سطوح پلاسمایی هپاتوکاین­ها (فتوئین A، فتوئین B)، HIIT دارای اثرگذاری بیشتری روی این متغیرها بوده است و HIIT نسبت به MICT توانسته بود که کاهش بیشتری در سطوح فتوئین B اعمال کند اما در فتوئین A تفاوتی بین گروه­های تمرینی نبود.

کلیدواژه‌ها

تمرین تداومی
تمرین تناوبی
هپاتوکاین
چاقی

عنوان مقاله English

The effect of twelve weeks of continuous training and high intensity interval training on the levels of some hepatokines in obese men

نویسندگان English

Akbar Ganjkhani
Tahereh Bagharpour
Nematul Lae Nemati
Islamic Azad University
چکیده English

Introduction: The aim of the present study was to investigate the effect of high-intensity interval training and continuous training on the serum levels of fetuin A and fetuin B in obese men.

Method: For this purpose, after homogenization, 45 obese males (Weight: 94.65±2.02 kg, Age: 26±5 yrs, BMI: 33.62±1.41 kg.m2) were randomly divided into 3 groups: control group (15 people), continuous training group (15 people), and interval training group (15 people) based on individual characteristics. The training groups were done in 12 weeks and 3 sessions per week. Interval training consisted of 6 bursts of 3-minute at 90% of maximal oxygen uptake (VO2 max) running, with 3 minutes of active recovery between each burst at 50% VO2 max running on a treadmill. Continuous training consisted of 50 minutes of running at 70% of VO2 max running on a treadmill. Blood samples were taken before and 48 hours after the last training session and were used for index analysis using an ELISA device.

Results: Analyses covariance test for the plasma levels of fetuin A and fetuin B showed that the difference between groups (control, MICT and HIIT) was statistically significant (p<0.001). According to the results of post hoc Bonferroni test for fetuin A level, there is a significant difference between the HIIT (p<0.001) and MICT (p=0.007) groups with the control group. Also, based on the results of post hoc Bonferroni test for fetuin B levels, there is a significant difference between the HIIT (p<0.001) and MICT (p<0.001) groups with the control group. In addition, fetuin B reduction in the HIIT group compared to MICT group was statistically significant (p<0.001).

Conclusion: The present results showed that although both MICT and HIIT had positive effects on reducing plasma levels of hepatokines (fetuin-A and fetuin-B), HIIT was more effective in influencing these variables. Specifically, HIIT resulted in a greater reduction in fetuin-B levels compared to MICT, while no significant difference was observed between the training groups in terms of fetuin-A levels.

کلیدواژه‌ها English

continuous training
Interval training
hepatokine
Obesity
1. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. Jama. 2014;311(8):806-14. doi: 10.1001/jama.2014.732.
2. Delfan M, Saeidi A, Supriya R, Escobar KA, Laher I, Heinrich KM, et al. Enhancing cardiometabolic health: unveiling the synergistic effects of high-intensity interval training with spirulina supplementation on selected adipokines, insulin resistance, and anthropometric indices in obese males. Nutrition & Metabolism. 2024;21(1):11. doi: 10.1186/s12986-024-00785-0.
3. Delfan M, Behzadi NJ, Juybari RA, Daneshyar S, Saeidi A, Willems ME, et al. Adipokine modulation in obesity: Evaluating the integrative impact of chlorella vulgaris supplementation and interval resistance training in obese males. Journal of functional foods. 2024;119:106315. doi: 10.1016/j.jff.2024.106315.
4. Prenzler NK, Macke C, Horn R, Brabant G, Pabst R, Richter M, et al. Obesity influences the food consumption and cytokine pattern in ghrelin-treated endotoxemic rats. Life sciences. 2007;81(1):80-7. doi: 10.1016/j.lfs.2007.04.030.
5. Pashaei Z, Malandish A, Alipour S, Jafari A, Laher I, Hackney AC, et al. Effects of HIIT training and HIIT combined with circuit resistance training on measures of physical fitness, miRNA expression, and metabolic risk factors in overweight/obese middle-aged women. BMC Sports Science, Medicine and Rehabilitation. 2024;16(1):123. doi: 10.1186/s13102-024-00904-7.
6. Saeidi A, Motamedi P, Hoteit M, Sadek Z, Ramadan W, Dara MM, et al. Impact of spinach thylakoid extract-induced 12-week high-intensity functional training on specific adipokines in obese males. Journal of the International Society of Sports Nutrition. 2024;21(1):2398467. doi: 10.1080/15502783.2024.2398467.
7. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001;50(8):1844-50. doi: 10.2337/diabetes.50.8.1844.
8. Nemati M, Bozorgtabar N, Hoteit M, Sadek Z, Almaqhawi A, Rashidy-Pour A, et al. Antioxidant supplementation boosts the advantages of CrossFit workouts on oxidative and muscle damage markers in obese males. Nutrition & Metabolism. 2024;21(1):91. doi: 10.1186/s12986-024-00860-6.
9. Tohidi M, Harati H, Hadaegh F, Mehrabi Y, Azizi F. Association of liver enzymes with incident type 2 diabetes: tehran lipid and glucose study. Iranian Journal of Diabetes and Metabolism. 2007;7(2):167-76. doi: 10.1186/1472-6823-8-5.
10. Tilg H, Moschen AR. Insulin resistance, inflammation, and non-alcoholic fatty liver disease. Trends in Endocrinology & Metabolism. 2008;19(10):371-9. doi: 10.1016/j.tem.2008.08.005.
11. Bugianesi E, Gastaldelli A, Vanni E, Gambino R, Cassader M, Baldi S, et al. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia. 2005;48:634-42. doi: 10.1007/s00125-005-1682-x.
12. Zhu K, Wang Y, Shu P, Zhou Q, Zhu J, Zhou W, et al. Increased serum levels of fetuin B in patients with coronary artery disease. Endocrine. 2017;58(1):97-105. doi: 10.1007/s12020-017-1387-1.
13. Reinehr T, Roth CL. Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. The Journal of Clinical Endocrinology & Metabolism. 2008;93(11):4479-85. doi: 10.1210/jc.2008-1505.
14. Pérez-Sotelo D, Roca-Rivada A, Larrosa-García M, Castelao C, Baamonde I, Baltar J, et al. Visceral and subcutaneous adipose tissue express and secrete functional alpha2hsglycoprotein (fetuin a) especially in obesity. Endocrine. 2017;55:435-46. doi: 10.1007/s12020-016-1132-1.
15. Mathews ST, Singh GP, Ranalletta M, Cintron VJ, Qiang X, Goustin AS, et al. Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. Diabetes. 2002;51(8):2450-8. doi: 10.2337/diabetes.51.8.2450.
16. Dasgupta S, Bhattacharya S, Biswas A, Majumdar SS, Mukhopadhyay S, Ray S, et al. NF-κB mediates lipid-induced fetuin-A expression in hepatocytes that impairs adipocyte function effecting insulin resistance. Biochemical journal. 2010;429(3):451-62. doi: 10.1042/BJ20100330.
17. Pal D, Dasgupta S, Kundu R, Maitra S, Das G, Mukhopadhyay S, et al. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nature medicine. 2012;18(8):1279. doi: 10.1038/nm.2851.
18. Kralisch S, Hoffmann A, Klöting N, Bachmann A, Kratzsch J, Blüher M, et al. The novel adipokine/hepatokine fetuin B in severe human and murine diabetic kidney disease. Diabetes & metabolism. 2017;43(5):465. doi: 10.1016/j.diabet.2017.01.005.
19. Meex RC, Hoy AJ, Morris A, Brown RD, Lo JC, Burke M, et al. Fetuin B is a secreted hepatocyte factor linking steatosis to impaired glucose metabolism. Cell metabolism. 2015;22(6):1078-89. doi: 10.1016/j.cmet.2015.09.023.
20. Zhu J, Wan X, Wang Y, Zhu K, Li C, Yu C, et al. Serum fetuin B level increased in subjects of nonalcoholic fatty liver disease: a case-control study. Endocrine. 2017;56(1):208-11. doi: 10.1007/s12020-016-1112-5.
21. Blumenthal JB, Gitterman A, Ryan AS, Prior SJ. Effects of exercise training and weight loss on plasma Fetuin-a levels and insulin sensitivity in overweight older men. Journal of diabetes research. 2017;2017. doi: 10.1155/2017/1492581.
22. Schultes B, Frick J, Ernst B, Stefan N, Fritsche A. The effect of 6-weeks of aerobic exercise training on serum fetuin-A levels in non-diabetic obese women. Experimental and clinical endocrinology & diabetes. 2010;118(10):754-6. doi: 10.1055/s-0030-1253418.
23. Jensen MK, Bartz TM, Mukamal KJ, Djoussé L, Kizer JR, Tracy RP, et al. Fetuin-A, type 2 diabetes, and risk of cardiovascular disease in older adults: the cardiovascular health study. Diabetes care. 2013;36(5):1222-8. doi: 10.2337/dc12-1591.
24. Van Aggel-Leijssen DP, Saris WH, Wagenmakers AJ, Senden JM, Van Baak MA. Effect of exercise training at different intensities on fat metabolism of obese men. Journal of applied physiology. 2002;92(3):1300-9. doi: 10.1152/japplphysiol.00030.2001.
25. Boutcher SH. High-intensity intermittent exercise and fat loss. Journal of obesity. 2010;2011.
26. Eston R, Evans H, Faulkner J, Lambrick D, Al-Rahamneh H, Parfitt G. A perceptually regulated, graded exercise test predicts peak oxygen uptake during treadmill exercise in active and sedentary participants. European journal of applied physiology. 2012;112(10):3459-68. doi: 10.1007/s00421-012-2326-8.
27. Saeidi A, Shishvan SR, Soltani M, Tarazi F, Doyle-Baker PK, Shahrbanian S, et al. Differential effects of exercise programs on neuregulin 4, body composition and cardiometabolic risk factors in men with obesity. Frontiers in physiology. 2022;12:797574. doi: 10.3389/fphys.2021.797574.
28. Bartlett JD, Close GL, MacLaren DP, Gregson W, Drust B, Morton JP. High-intensity interval running is perceived to be more enjoyable than moderate-intensity continuous exercise: implications for exercise adherence. Journal of sports sciences. 2011;29(6):547-53. doi: 10.1080/02640414.2010.545427.
29. Zhang Y, Wang Y, Liu J. Friend or foe for obesity: How hepatokines remodel adipose tissues and translational perspective. Genes & Diseases. 2022. doi: 10.1016/j.gendis.2021.12.011.
30. Kolahdouzi S, Baghadam M, Kani-Golzar FA, Saeidi A, Jabbour G, Ayadi A, et al. Progressive circuit resistance training improves inflammatory biomarkers and insulin resistance in obese men. Physiology & behavior. 2019;205:15-21. doi: 10.1016/j.physbeh.2018.11.033.
31. Weigert C, Hoene M, Plomgaard P. Hepatokines—a novel group of exercise factors. Pflügers Archiv-European Journal of Physiology. 2019;471:383-96. doi: 10.1007/s00424-018-2216-y.
32. Mukhuty A, Mondal SA, Mukhopadhyay S. Hepatokines and Adipokines in Metabolic Syndrome. Annals of the National Academy of Medical Sciences (India). 2023;59(01):004-12. doi:
10.1055/s-0042-1760087.
33. Trepanowski J, Mey J, Varady K. Fetuin-A: a novel link between obesity and related complications. International journal of obesity. 2015;39(5):734-41. doi: 10.1038/ijo.2014.203.
34. Ju H, Zhou Z, Sun M, Chen H. Association of fetuin-A to adiponectin ratio with metabolic syndrome: a cross-sectional study. Endocrine. 2017;58:190-3. doi: 10.1007/s12020-017-1383-5.
35. Stefan N, Sun Q, Fritsche A, Machann J, Schick F, Gerst F, et al. Impact of the adipokine adiponectin and the hepatokine fetuin-A on the development of type 2 diabetes: prospective cohort-and cross-sectional phenotyping studies. PloS one. 2014;9(3):e92238. doi: 10.1371/journal.pone.0092238.
36. Pan X, Wen SW, Bestman PL, Kaminga AC, Acheampong K, Liu A. Fetuin-A in Metabolic syndrome: A systematic review and meta-analysis. PloS one. 2020;15(3):e0229776. doi: 10.1371/journal.pone.0229776.
37. Dadash Nejad F, Gholami M, Soheili S. The effect of eight-week combined exercise training (resistance-endurance) and Omega-3 ingestion on the levels of fetuin-A and metabolic profile in obese elderly women. Daneshvar Medicine. 2020;27(4):35-44.
38. Jialal I, Pahwa R. Fetuin-A is also an adipokine. Lipids in health and disease. 2019;18:1-2. doi: 10.1186/s12944-019-1021-8.
39. Takata H, Ikeda Y, Suehiro T, Ishibashi A, Inoue M, Kumon Y, et al. High glucose induces transactivation of the α2-HS glycoprotein gene through the ERK1/2 signaling pathway. Journal of atherosclerosis and thrombosis. 2009;16(4):448-56. doi: 10.5551/jat.no950.
40. Ramírez-Vélez R, García-Hermoso A, Hackney AC, Izquierdo M. Effects of exercise training on Fetuin-a in obese, type 2 diabetes and cardiovascular disease in adults and elderly: a systematic review and Meta-analysis. Lipids in health and disease. 2019;18:1-11. doi: 10.1186/s12944-019-0962-2.
41. Habibian M, Abbaszadeh TF. The effect of regular exercise training on fetuin-a and adiponectin levels in postmenopausal owerweight women with type 2 diabetes mellitus. 2020 .doi: 10.52547/jmj.18.2.49.
42. Ghalavand A, Ghobadi MR, Motamedi P, Delaramnasab M. Reduction of fetuin B in adaptation to pyramidal aerobic exercises and its role in modulating insulin resistance and serum aminotransferases in patients with type 2 diabetes. EBNESINA. 2023;25(1):13-20. doi: 10.22034/25.1.13.
43. Ghiyami SH, Afroundeh R, Pourvaghar MJ, Sadeghi A, Katebi L. The Effect Of 8 Weeks Combined Training Along With The Use Of Mulberry Leaf Extract On Serum Levels Of Fetuin A And Fetuin B Levels In Elderly Men With Type Diabetes 2. Studies In Medical Sciences. 2022;33(6):426-40. doi: 10.52547/umj.33.6.426.
پژوهش در طب ورزشی و فناوری

مقالات آماده انتشار، پذیرفته شده
انتشار آنلاین از 01 آبان 1398